Robert W. Baird Forecasts Strong Price Appreciation for AdaptHealth (NASDAQ:AHCO) Stock

AdaptHealth (NASDAQ:AHCO) had its target price boosted by investment analysts at Robert W. Baird from $14.00 to $16.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s price objective suggests a potential upside of 44.14% from the stock’s previous close.

A number of other brokerages have also weighed in on AHCO. Truist Financial increased their target price on AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday. UBS Group lowered their target price on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Royal Bank of Canada increased their target price on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research note on Wednesday. Finally, Canaccord Genuity Group increased their target price on AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $13.80.

AdaptHealth Stock Performance

Shares of NASDAQ AHCO opened at $11.10 on Thursday. AdaptHealth has a 52 week low of $8.35 and a 52 week high of $11.90. The stock has a market capitalization of $1.49 billion, a PE ratio of -6.73, a price-to-earnings-growth ratio of 1.08 and a beta of 1.12. The stock has a 50 day moving average price of $9.87 and a 200 day moving average price of $10.21. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

Institutional Investors Weigh In On AdaptHealth

Large investors have recently modified their holdings of the business. Assetmark Inc. acquired a new stake in shares of AdaptHealth in the 4th quarter valued at $28,000. Blue Trust Inc. boosted its holdings in shares of AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after purchasing an additional 1,115 shares in the last quarter. Quarry LP boosted its holdings in shares of AdaptHealth by 4,596.9% in the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after purchasing an additional 5,838 shares in the last quarter. CIBC Asset Management Inc acquired a new stake in shares of AdaptHealth in the 3rd quarter valued at $122,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its holdings in shares of AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after purchasing an additional 1,690 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.